- Who can participate: Adults aged 18 to 65 years with a diagnosis of chronic pain for at least 6 months are eligible. Participants must not have any other significant medical conditions that could interfere with the study results.
- Study details: Participants will be randomly assigned to receive either the investigational treatment or a placebo. The study will involve regular assessments of pain levels and monitoring for any side effects.

